Human Primary Umbilical Vein Endothelial Cells Size:T25 Flask IFN alpha -2 derived mutants

IFN alpha -2 derived mutants with reduced IFNR2 binding inhibited HIV replication and mutants with more IFNAR1 binding potentiated antiviral activity (6)

Swissprot No Q9HCB6 Gene Accession NP_006099 WB Predicted band size 91 kDa WB Positive control WB Recommended dilution 200-1000 IHC predicted cell location Predicted cell location: Cytoplasm IHC positive control Positive control: Human liver cancer IHC Recommed dilution Recommended dilution: 25-100 Storage

and two pseudogenes of this gene are located on the short arm of chromosome 16

consider using such enhanced membranes or optimizing the combination of membrane

Human Primary Umbilical Vein Endothelial Cells Size:T25 Flask IFN alpha -2 derived mutantsDescription Human Primary Umbilical Vein Endothelial Cells from Cell Biologics are isolated from human umbilical vein tissue. Human Primary Umbilical Vein Endothelial Cells are grown in T25 tissue culture flasks pre coated with gelatin based solution for 2 min and incubated in Cell Biologics Culture Complete Growth Medium generally for 3 7 days. Cultures are then expanded. Prior to shipping, cells at passage 3 are detached from flasks and immediately